Product
IVMP
1 clinical trial
2 indications
Indication
EfgartigimodIndication
Neuromyelitis OpticaClinical trial
Effectiveness and Safety of Efgartigimod in the Acute Phase of Neuromyelitis Optica Spectrum Disorders-a Multicentric, Controlled, Retrospective, Real-Word StudyStatus: Not yet recruiting, Estimated PCD: 2024-11-05